🔎 Trials Near Me

Dachaigh › Diabetes Type 1 › California › San Francisco

Sgrùdaidhean clionaigeach Diabetes Type 1 ann an San Francisco, CA

Tha 14 sgrùdaidhean airson Diabetes Type 1 a’ lorg phàirtichean aig làraichean ann agus timcheall air San Francisco (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Type 1 Diabetes Extension Study

A’ fastadhSgrùdadh amharc
  • UCSF School of Medicine, San Francisco
Aoisean 8 gu 35 · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT02734277

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

A’ fastadhÌre 3
  • University of California San Francisco - Mission Bay- Site Number : 8400011, San Francisco
Aoisean 1 gu 25 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07088068

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

A’ fastadhÌre 2
  • University of California San Francisco, San Francisco
Aoisean 8 gu 45 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT07142252

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

A’ fastadhÌre 1/2
  • UCSF, San Francisco
Aoisean 9 gu 20 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07061574

A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

A’ fastadhÌre 3
  • University of California San Francisco, San Francisco
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT04786262

HLA Demographics Study in Adults With Type 1 Diabetes

A’ fastadhSgrùdadh amharc
  • University of California, San Francisco, San Francisco
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT06860516

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

A’ fastadhÌre 2
  • University of California San Francisco Benioff Children's Hospital, San Francisco
Aoisean 5 gu 40 · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT07187531

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

A’ fastadhÌre 2
  • University of California San Francisco, San Francisco
Aoisean 6 gu 17 · Gach gnè · Air ùrachadh 13 Lùna 2026 · NCT07224321

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

A’ fastadhÌre 1
  • University of California - San Francisco, San Francisco
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT06919354

Commercial or Open Source Closed Loop Impact on Pregnancy Study

A’ fastadhSgrùdadh amharc
  • University of California, San Francisco, San Francisco
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 27 Iuch 2026 · NCT06654713

Automated Insulin for Management of Intrapartum Glycemia

A’ fastadh
  • University of California, San Francisco, San Francisco
Aoisean 18 gu 55 · Banairean · Air ùrachadh 13 Iuch 2026 · NCT06883344

Registry for Stage 2 Type 1 Diabetes

A’ fastadhSgrùdadh amharc
  • University of California San Francisco - Mission Bay- Site Number : 8400005, San Francisco
Gach aois · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT06481904

A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States

A’ fastadhSgrùdadh amharc
  • Investigational Site, San Francisco
Aoisean 8 agus nas sine · Gach gnè · Air ùrachadh 3 Dùbh 2025 · NCT07260110

TrialNet Pathway to Prevention of T1D

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • University of California San Francisco, San Francisco
Aoisean 2 gu 45 · Gach gnè · Air ùrachadh 1 Iuch 2025 · NCT00097292

Sgrùdaidhean Diabetes Type 1 ann am bailtean eile

Sgrùdaidhean eile ann an San Francisco

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.